Synfini, Inc. is advancing small molecule drug discovery through its Agile AI Foundry—an integrated platform uniting artificial intelligence, chemistry automation, and cloud-native workflows to deliver better molecules, faster. Powered by an expansive library of chemical transformations deployable across multi-step routes and scale, the platform combines best-in-class route-based and generative AI tools to design, synthesize, and deliver the highest quality optimized molecules.
Synthetic feasibility is central to the Synfini platform, with computational methods and expert chemist-led methodologies working in concert to ensure reliable, reproducible molecular generation. Synfini provides rapid, cost-effective progression from target to preclinical candidate, Synfini-validated targets ready for partnering, and synthesis solutions for complex discovery challenges through custom AI design.